Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Background: There are limited data regarding intermittently scanned continuous glucose monitoring (isCGM) in pregnancy for women with Type 2 diabetes. We have tested the acceptability and feasibility of an isCGM method using Libre device. Method: In a hospital-based service improvement project, 23 pregnant women (March 2022-April 2023), with Type 2 diabetes got isCGM for monitoring from 20 weeks until delivery. Women completed a structured and validated questionnaire assessing satisfaction, equipment issue, relationship with diabetes team. Results: Two-thirds of the women were satisfied with the convenience and found it reliable. 86% wanted to use it for future pregnancies, and 90% would recommend it to others. Sensor falls off was seen in three obese women and about a tenth felt the reliability was poor in extreme ranges of sugar levels. The relationship with the diabetes team was rated high. Conclusion: isCGM could be a useful and well-received tool for improving glycaemic control in pregnancies with Type 2 diabetes.

Original publication

DOI

10.1177/1753495X241233030

Type

Journal article

Journal

Obstetric Medicine

Publication Date

01/01/2024